Published in Cornea on April 01, 2010
In Vivo confocal microscopic changes of the corneal epithelium and stroma in patients with herpes zoster ophthalmicus. Am J Ophthalmol (2015) 2.00
Inflammation and the nervous system: the connection in the cornea in patients with infectious keratitis. Invest Ophthalmol Vis Sci (2011) 1.37
Cellular changes of the corneal epithelium and stroma in herpes simplex keratitis: an in vivo confocal microscopy study. Ophthalmology (2012) 0.95
Diagnosing ocular surface squamous neoplasia in East Africa: case-control study of clinical and in vivo confocal microscopy assessment. Ophthalmology (2013) 0.84
Advances in Confocal Microscopy of the Eye. Biomed Res Int (2016) 0.75
What biomarkers explain about pterygium OCT pattern. Graefes Arch Clin Exp Ophthalmol (2016) 0.75
Correlation between corneal innervation and inflammation evaluated with confocal microscopy and symptomatology in patients with dry eye syndromes: a preliminary study. Graefes Arch Clin Exp Ophthalmol (2017) 0.75
Preservatives in eyedrops: the good, the bad and the ugly. Prog Retin Eye Res (2010) 2.68
The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction. Invest Ophthalmol Vis Sci (2011) 2.66
The ocular surface of glaucoma patients treated over the long term expresses inflammatory markers related to both T-helper 1 and T-helper 2 pathways. Ophthalmology (2007) 2.10
Clinical and biologic features of CD4(+)CD56(+) malignancies. Blood (2002) 2.06
Tear osmolarity in the diagnosis and management of dry eye disease. Am J Ophthalmol (2011) 1.94
Conjunctival proinflammatory and proapoptotic effects of latanoprost and preserved and unpreserved timolol: an ex vivo and in vitro study. Invest Ophthalmol Vis Sci (2004) 1.70
In vitro study of inflammatory potential and toxicity profile of latanoprost, travoprost, and bimatoprost in conjunctiva-derived epithelial cells. Invest Ophthalmol Vis Sci (2005) 1.63
Th1 and Th2 responses on the ocular surface in uveitis identified by CCR4 and CCR5 conjunctival expression. Am J Ophthalmol (2007) 1.41
Comparison of toxicological profiles of benzalkonium chloride and polyquaternium-1: an experimental study. J Ocul Pharmacol Ther (2006) 1.31
In vitro effects of preservative-free tafluprost and preserved latanoprost, travoprost, and bimatoprost in a conjunctival epithelial cell line. Curr Eye Res (2008) 1.29
Switching from a preserved to a preservative-free prostaglandin preparation in topical glaucoma medication. Acta Ophthalmol (2010) 1.29
In vivo confocal microscopy of the ocular surface: from bench to bedside. Curr Eye Res (2013) 1.27
Multiple endpoint analysis of the 3D-reconstituted corneal epithelium after treatment with benzalkonium chloride: early detection of toxic damage. Invest Ophthalmol Vis Sci (2009) 1.25
In vivo corneal confocal microscopy comparison of intralase femtosecond laser and mechanical microkeratome for laser in situ keratomileusis. Invest Ophthalmol Vis Sci (2006) 1.23
In vitro comparison of cytoprotective and antioxidative effects of latanoprost, travoprost, and bimatoprost on conjunctiva-derived epithelial cells. Invest Ophthalmol Vis Sci (2005) 1.22
Contribution of in vivo confocal microscopy to the diagnosis and management of infectious keratitis. Ocul Surf (2009) 1.21
In vivo confocal microscopy study of blebs after filtering surgery. Ophthalmology (2005) 1.20
Prospective, unmasked evaluation of the iStent® inject system for open-angle glaucoma: synergy trial. Adv Ther (2014) 1.15
Ocular surface epithelial thickness evaluation with spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci (2011) 1.15
In vitro effects of preserved and unpreserved antiglaucoma drugs on apoptotic marker expression by human trabecular cells. Graefes Arch Clin Exp Ophthalmol (2003) 1.15
Dry eye disease, dry eye symptoms and depression: the Beijing Eye Study. Br J Ophthalmol (2013) 1.15
A multicentre, double-masked, randomized, controlled trial assessing the effect of oral supplementation of omega-3 and omega-6 fatty acids on a conjunctival inflammatory marker in dry eye patients. Acta Ophthalmol (2011) 1.11
Measurement of health-related quality of life with glaucoma: validation of the Glau-QoL 36-item questionnaire. Acta Ophthalmol (2007) 1.11
Efficacy and safety of preservative-free latanoprost eyedrops, compared with BAK-preserved latanoprost in patients with ocular hypertension or glaucoma. Br J Ophthalmol (2012) 1.10
Corneal nerve structure and function in patients with non-sjogren dry eye: clinical correlations. Invest Ophthalmol Vis Sci (2013) 1.09
CCR 4 and CCR 5 expression in conjunctival specimens as differential markers of T(H)1/ T(H)2 in ocular surface disorders. J Allergy Clin Immunol (2005) 1.09
Flow cytometry in conjunctival impression cytology: a new tool for exploring ocular surface pathologies. Exp Eye Res (2004) 1.08
New tools for the evaluation of toxic ocular surface changes in the rat. Invest Ophthalmol Vis Sci (2007) 1.08
Toxicological evaluation of preservative-containing and preservative-free topical prostaglandin analogues on a three-dimensional-reconstituted corneal epithelium system. Br J Ophthalmol (2011) 1.06
Tear film aberration dynamics and vision-related quality of life in patients with dry eye disease. Ophthalmology (2012) 1.04
Comparative anatomy of laboratory animal corneas with a new-generation high-resolution in vivo confocal microscope. Curr Eye Res (2006) 1.04
Efficacy and safety of 0.18% sodium hyaluronate in patients with moderate dry eye syndrome and superficial keratitis. Graefes Arch Clin Exp Ophthalmol (2004) 1.02
The impact of dry eye disease on visual performance while driving. Am J Ophthalmol (2013) 1.02
In vivo confocal microscopy in fungal keratitis. Br J Ophthalmol (2006) 1.01
In vivo confocal microscopy and ex vivo flow cytometry: new tools for assessing ocular inflammation applied to rabbit lipopolysaccharide-induced conjunctivitis. Mol Vis (2006) 1.01
Measurement of treatment compliance using a medical device for glaucoma patients associated with intraocular pressure control: a survey. Clin Ophthalmol (2010) 1.00
Therapeutic efficacy of trehalose eye drops for treatment of murine dry eye induced by an intelligently controlled environmental system. Mol Vis (2012) 0.96
The relationship between subbasal nerve morphology and corneal sensation in ocular surface disease. Invest Ophthalmol Vis Sci (2012) 0.96
Fluoroquinolone eye drop-induced cytotoxicity: role of preservative in P2X7 cell death receptor activation and apoptosis. Invest Ophthalmol Vis Sci (2006) 0.96
Cornea in Marfan disease: Orbscan and in vivo confocal microscopy analysis. Invest Ophthalmol Vis Sci (2002) 0.96
Occludin gene expression as an early in vitro sign for mild eye irritation assessment. Toxicol In Vitro (2009) 0.95
Direct epithelial-stromal interaction in corneal wound healing: Role of EMMPRIN/CD147 in MMPs induction and beyond. Prog Retin Eye Res (2008) 0.95
Influence of sutureless 23-gauge sclerotomy architecture on postoperative intraocular pressure decrease: results of a multivariate analysis. Graefes Arch Clin Exp Ophthalmol (2012) 0.94
Epithelial basement membrane dystrophy: evaluation with the HRT II Rostock Cornea Module. Ophthalmology (2006) 0.94
Nutritional, lifestyle and environmental factors in ocular hypertension and primary open-angle glaucoma: an exploratory case-control study. Acta Ophthalmol (2012) 0.94
Influence of corneal biomechanical properties on surgically induced astigmatism in cataract surgery. J Cataract Refract Surg (2013) 0.94
LPS-stimulated inflammation and apoptosis in corneal injury models. Mol Vis (2007) 0.93
A new safety concern for glaucoma treatment demonstrated by mass spectrometry imaging of benzalkonium chloride distribution in the eye, an experimental study in rabbits. PLoS One (2012) 0.93
In vitro and in vivo comparative toxicological study of a new preservative-free latanoprost formulation. Invest Ophthalmol Vis Sci (2012) 0.92
Pathways of corneal and ocular surface inflammation: a perspective from the cullen symposium. Ocul Surf (2005) 0.92
Conjunctiva-associated lymphoid tissue (CALT) reactions to antiglaucoma prostaglandins with or without BAK-preservative in rabbit acute toxicity study. PLoS One (2012) 0.91
EMMPRIN modulates epithelial barrier function through a MMP-mediated occludin cleavage: implications in dry eye disease. Am J Pathol (2011) 0.91
Live conjunctiva-associated lymphoid tissue analysis in rabbit under inflammatory stimuli using in vivo confocal microscopy. Invest Ophthalmol Vis Sci (2009) 0.91
Reduced in vivo ocular surface toxicity with polyquad-preserved travoprost versus benzalkonium-preserved travoprost or latanoprost ophthalmic solutions. Ophthalmic Res (2012) 0.90
Tear film osmolarity in patients treated for glaucoma or ocular hypertension. Cornea (2012) 0.90
Xal-Ease: impact of an ocular hypotensive delivery device on ease of eyedrop administration, patient compliance, and satisfaction. Eur J Ophthalmol (2009) 0.90
In vivo architectural analysis of clear corneal incisions using anterior segment optical coherence tomography. J Cataract Refract Surg (2009) 0.89
In vitro comparative toxicology of polyquad-preserved and benzalkonium chloride-preserved travoprost/timolol fixed combination and latanoprost/timolol fixed combination. J Ocul Pharmacol Ther (2011) 0.89
Trehalose: an intriguing disaccharide with potential for medical application in ophthalmology. Clin Ophthalmol (2011) 0.89
Cytotoxicity of contact lens multipurpose solutions: role of oxidative stress, mitochondrial activity and P2X7 cell death receptor activation. Eur J Pharm Sci (2007) 0.89
Cytoprotective effects of hyaluronic acid and Carbomer 934P in ocular surface epithelial cells. Invest Ophthalmol Vis Sci (2002) 0.88
Appraisal of patient-reported outcome instruments available for randomized clinical trials in dry eye: revisiting the standards. Ocul Surf (2012) 0.88
Hyperosmolarity potentiates toxic effects of benzalkonium chloride on conjunctival epithelial cells in vitro. Mol Vis (2012) 0.87
Effects of toxic cellular stresses and divalent cations on the human P2X7 cell death receptor. Mol Vis (2008) 0.87
Comparison of the ocular tolerability of a latanoprost cationic emulsion versus conventional formulations of prostaglandins: an in vivo toxicity assay. Mol Vis (2009) 0.86
In vitro effects of preserved or preservative-free antiglaucoma medications on human complement system. Curr Eye Res (2003) 0.86
Ocular safety of cationic emulsion of cyclosporine in an in vitro corneal wound-healing model and an acute in vivo rabbit model. Mol Vis (2012) 0.86
Heidelberg retina tomograph II findings of Acanthamoeba keratitis. Ocul Immunol Inflamm (2005) 0.86
Localisation and quantification of benzalkonium chloride in eye tissue by TOF-SIMS imaging and liquid chromatography mass spectrometry. Anal Bioanal Chem (2013) 0.85
Filtering blebs and aqueous pathway an immunocytological and in vivo confocal microscopy study. Ophthalmology (2007) 0.85
Th1- and Th2-related chemokine and chemokine receptor expression on the ocular surface in endotoxin-induced uveitis. Mol Vis (2008) 0.85
Challenges in the clinical measurement of ocular surface disease in glaucoma patients. Clin Ophthalmol (2011) 0.85
Archipelago keratitis: a clinical variant of recurrent herpetic keratitis? Ophthalmology (2007) 0.85
In vivo confocal microscopy and anterior segment optical coherence tomography analysis of the cornea in nephropathic cystinosis. Ophthalmology (2009) 0.84
Effects of benzalkonium chloride on THP-1 differentiated macrophages in vitro. PLoS One (2013) 0.84
First-line latanoprost therapy in ocular hypertension or open-angle glaucoma patients: a 3-month efficacy analysis stratified by initial intraocular pressure. BMC Ophthalmol (2010) 0.84
Protein kinase C-zeta mediates retinal degeneration in response to TNF. J Neuroimmunol (2007) 0.84
CXCR3 antagonism of SDF-1(5-67) restores trabecular function and prevents retinal neurodegeneration in a rat model of ocular hypertension. PLoS One (2012) 0.83